Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Paratek Pharmaceuticals, Inc. | Financial_Report.xls |
10-Q - FORM 10-Q - Paratek Pharmaceuticals, Inc. | d246014d10q.htm |
EX-31.1 - CERTIFICATION OF THE CEO PURSUANT TO SECTION 302 - Paratek Pharmaceuticals, Inc. | d246014dex311.htm |
EX-31.2 - CERTIFICATION OF THE CFO PURSUANT TO SECTION 302 - Paratek Pharmaceuticals, Inc. | d246014dex312.htm |
Exhibit 32.1
Certification of Chief Executive Officer and Chief Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of Transcept Pharmaceuticals, Inc. (the Company) hereby certify, to such officers knowledge, that:
(i) the accompanying Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2011 (the Report) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 10, 2011 | /s/ Glenn A. Oclassen | |||
Glenn A. Oclassen President and Chief Executive Officer | ||||
Date: November 10, 2011 | /s/ Thomas P. Soloway | |||
Thomas P. Soloway Senior Vice President, Operations and Chief Financial Officer |